Medical devices, healthcare technology and the business of care
510(k) clearance · K263422

Mint ACE Pump

Beta Bionics, Inc. · Decision date Oct 21, 2026

MEDTECHLEDGER EXPLANATIONK263422

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for the Mint ACE Pump, submitted by Beta Bionics, Inc. of Irvine, California, under 510(k) number K263422. The agency lists the device classification as Alternate Controller Enabled Insulin Infusion Pump, regulation number 880.5730, product code QFG, with a Clinical Chemistry review panel. The application was received on 09/25/2026 and decided on 10/21/2026. A SESE finding is a 510(k) clearance, not a premarket approval of a new device.

The public record identifies the submission as a Special-type 510(k) that was not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The listed applicant contact and correspondent contact are the same. The available material does not describe the specific device components, the predicate device, or the basis for the equivalence determination; those details would sit in the underlying 510(k) summary and review documents, which are not included here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Clinical Chemistry
Decision date
Oct 21, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263422
Regulatory pathway
510(k) premarket notification
Product code
QFG
Decision code
SESE
Decision date
Oct 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Alternate Controller Enabled Insulin Infusion Pump.

Product code
QFG
FDA device class
2

FDA decision timeline

  1. K263422 received

    Application receipt date recorded by FDA.

  2. K263422 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QFG

Product / regulatory recordCompanyPathwayDecision dateSource
Beta Bionics, Inc.510(k) clearanceSep 11, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Beta Bionics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Irvine, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records